Infant Mortality Down in United States From 2005 to 2014

Share this content:
Infant Mortality Down in United States From 2005 to 2014
Infant Mortality Down in United States From 2005 to 2014

WEDNESDAY, March 22, 2017 (HealthDay News) -- From 2005 to 2014, infant mortality declined for all major racial and ethnic groups in the United States, except American Indian or Alaska Natives, according to a March data brief published by the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics (NCHS).

T.J. Mathews and Anne K. Driscoll, Ph.D., from the NCHS in Hyattsville, Md., examined the 2014 linked birth/infant death data from the National Vital Statistics System to assess trends in infant mortality in the United States.

The researchers found that infant mortality rates for the United States reached new lows for Hispanic, non-Hispanic white, non-Hispanic black, and Asian or Pacific Islander populations in 2014. Declines in infant mortality rates were seen for all race and Hispanic-origin subgroups from 2005 through 2014, except among American Indian or Alaska Native persons. The largest decreases were seen for infants of Asian or Pacific Islander and non-Hispanic black women (21 and 20 percent, respectively). From 2005-2007 to 2012-2014 there were declines for all Hispanic subgroups, with the largest declines among infants of Cuban and Puerto Rican women (19 and 17 percent, respectively). The infant mortality rate for sudden infant death syndrome decreased 29 percent from 2005 to 2014.

"From 2005 through 2014, infant mortality rates declined for four of the five leading causes of death, but there were no significant changes in the rates by cause of death in the past year," the authors write.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »